Clariane exploring French homecare business disposal options

Pan-European listed French nursing home group Clariane is exploring disposal options for its Hospitalisation à Domicile and Services de Soins Infirmiers à Domicile (HAD/SSIAD) business in France with the members of the Comité Social et Economique Central d'Entreprise (CSEC).

Orpea rebrands to emeis amid turmoil

French care home operator Orpea has rebranded itself as emeis, in the wake of a tumultuous period marked by allegations of mistreatment in its facilities. The company's decision to change its name comes as it attempts to distance itself from the scandals that have plagued it since 2022, including accusations of abuse within its French care homes.

Clariane exits the UK and makes progress on Dutch and Belgium sale

Pan-European listed French nursing home group Clariane has successfully exited the UK with the sale of its Berkley Care subsidiary. The group has also made progress on the sale of its Belgian and Dutch branches, but has not yet secured a buyer for these.

Meet the new generation of doctorpreneurs

Doctors are becoming increasingly interested in setting up clinics and running them as proper businesses. We spoke to Romesh Angunawela, who has recently completed an MBA especially for physicians in the US, and is the co-founder of OCL Vision, a three-clinic ophtha group in the UK. He shared his view on this trend and the factors driving it.

Medicharme enters liquidation

Medicharme, a medium sized French nursing home group owned by UK PE investor G Squared, has entered liquidation. The company became insolvent due to rising costs and low occupancy. The company's 43 facilities will continue to operate as normal for the time being. Takeover offers for the facilities will be examined by the courts on March 21.

Orpea issues reverse share split

Embattled French nursing home group Orpea has announced it will pursue a reverse share split on all outstanding company shares. This means current shares which are valued at around €0.01 each will be exchanged for new shares valued at €10 each, at an exchange rate of 1,000-for-one.

Find Us